Rectal cancer originates in the rectum (the last inches of the intestinal tract) and is commonly marked by symptoms such as unintended weight loss, extreme fatigue, rectal bleeding, and variations in appetite and frequency. It begins in small clumps known as polyps, most commonly benign, that may develop into cancer overtime. Although its cause is unknown, smoking, inflammatory bowel disease, an inactive lifestyle, a high-fat and low-fiber diet, as well as old age are common risk factors for rectal cancer. Treatments for rectal cancer include surgery, chemotherapy, and radiation therapy. Recurrent rectal cancer occurs when the cancer has returned or progressed following initial treatments such as surgery, radiation, or chemotherapy. If this occurs, changes to current therapy may be taken into account, perhaps incorporating new or not used treatments.
Recurrent Rectal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Recurrent Rectal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 880 products for the study of Recurrent Rectal Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.